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1. Introduction 
Carcinogenic polycyclic hydrocarbons are meta- 
bolized to epoxides by mammalian microsomal mono- 
oxygenases [l-4] and it has been suggested that this 
type of reactive intermediate is responsible for the. 
biological effects, including carcinogenesis, attributed 
to the parent hydrocarbons [5] . Although synthetic 
K-region epoxides possess many properties relevant 
to the initiation of tumours [6 ] , some previous work 
has indicated that K-region epoxides are not the actual 
epoxides involved in reactions with the nucleic acids 
of cells treated with the parent hydrocarbons [7]. 
8,9-Dihydro-8,9-dihydroxy-benz(a)anthracene lO,ll- 
oxide, a new type of epoxide that is formed on the 
isolated 10,l l-double bond of the 8,9-diol of benz(a)- 
anthracene, has recently been detected as a metabolite 
of the dihydrodiol and has also been prepared by 
synthesis [8]. The experiments described here provide 
evidence that when hamster embryo cells in culture 
are treated with benz (a) anthracene, the DNA 
products formed result from the reaction of 
8,9dihydroxybenz(a)anthracene 10,l l-oxide with this 
nucleic acid. Similar results have been obtained when 
rat-liver microsomal preparations are incubated with 
the 8,9-dihydrodiol of benz(a)anthracene and DNA. 
As an important corollary, these results also provide 
some of the strongest evidence so far obtained in sup- 
port of the hypothesis that epoxides are the metabolic- 
ally-activated intermediates formed from polycyclic 
hydrocarbons. 
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2. Materials and methods 
2.1. Materials 
3 H-Labelled benz(a)anthracene (specific activity 
26 Ci/mmole) was obtained from the Radiochemical 
Centre, Amersham, Bucks and 3H-labelled 8,9dihydro- 
8,9-dihydroxybenz(a)anthracene and 3 H-lab&d 
8,9-dihydro-8,9-dihydroxybenz(a)anthracene 10,l l- 
oxide (both of specific activity 0.6 Ci/mmole) prepared 
using the method described [8]. Dulbecco’s MEM and 
foetal calf serum were obtained from Biocult Labora- 
tories Ltd., Paisley, Scotland, caffeine from Hopkin 
and Williams Ltd., Chadwell Heath, Essex and DNA, 
Type III from Salmon testes, from the Sigma Chemical 
Co., St. Louis, MO., USA. Glucose 6-phosphate, glucose 
6-phosphate dehydrogenase and NADPH were purchased 
from Boehringer, Mannheim, W. Germany. 
2.2. Reaction of epoxides with DNA 
8,9-Dihydro-8,9-dihydroxybenz(a)anthracene 10, 
1 l-oxide (2.5 mg) or benz(a)anthracene 5,6-oxide 
(2.5 mg) in ethanol (25 ml) was mixed with a solution 
of Salmon sperm DNA (50 mg) previously deproteinized 
by a detergent-salt procedure [9], in Tris buffer pH 7.4, 
0.01 M (50 ml) and incubated at 37’C for 4 hr. After 
incubation, the solution was extracted with solvent 
and the DNA reisolated as described previously [5]. 
2.3. DNA from hamster embryo cell cultures 
Embryo cell suspensions were prepared from 1 l- 12 
day Syrian hamster embryos [lo], seeded (1 X 10’ 
North-Holland Publishing Company - Amsterdam 
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cells) into Dulbecco’s MEM (250 ml) containing 
foetal calf serum (15% v~v) and cultured at 37°C in 
Thompson bottles (21) under 10% CO2 in air for 4 
days. Cell monolayers were treated with ’ H-labelled 
be~(a)an~racene (2pg/ml), added to the medium 
as a solution in DMSO (final concentration, O.l%), and 
caffeine (1 mM) and 24 hr later the medium was 
removed and the cells harvested using an EDTA solu- 
tion (0.02%). The DNA was isolated and purified as 
previously described ]I 1 ] . 
2.4. Mi~roso~l ~n~butio~s with DNA 
Deproteinized Salmon sperm DNA (60 mg), dissolved 
in Tris buffer pH 7.4,O.Ol M (40 ml), was mixed with 
a washed rat-liver microsom~ preparation [I 2] (s S g 
liver) resuspended in Tris buffer (40 ml) containing 
NADPH (24 mg), glucose 6-phosphate (I 20 mg) and 
glucose 6-phosphate dehydrogenase (14 units) to 
which 3 H-labelled 8,9-dihydro-8,9-dihydroxybenz(a)- 
anthracene (262 fig) was added in acetone (0.2 ml). 
After incubation at 37°C for 30 min, the microsomes 
were pelleted by centrifugation and the DNA reisolated 
from the supematant and purified as described [ 121, 
DNA from reactions with epoxide, from treated 
hamster cell cultures or from microsomaf incubations 
with hydrocarbon derivatives was hydrolysed enzymic- 
ally to nucleosides [ 7,131 and chromatographed on
columns (75 X 1.5 cm) of Sephadex LH20 eluted with 
methanol-water gradients [7,13], Fractions (5.3 ml) 
were collected and examined at 260 run for U.V. 
absorbing materials and the radioactivity present 
determined by liquid scintillation counting. 
2.6. Thin-layer chromatography 
Fractions eluted from chromato~aphy columns 
that contained DNA-hydrolysis products were pooled 
and evaporated to a small volume and the solution 
applied to Eastman Kodak 6060 Chromogr~ sheets 
that were developed with solvent (a) butan-l-01: 
propan- l 01: aq. 2M-NH3 (2: 1: 1, by vol) or with sol- 
vent (b) ethyl acetate:methanol:water:formic ac d, 
90% (100:25: 20: 1, by vol). Chromatograms were 
examined under U.V. light and U.V. absorption, at 
260 nm, and radioactivity measured after elution of 
areas of the chromatograms with ethanol. 
Fig. 1. Sephadex LH20 column elution profiles obtained follow- 
ing reactions with benz(a)anthracene derivatives. (A) Hydroiysate 
of DNA from hamster embryo ceils treated with “H-benz(a)- 
anthracene (o -0) co-chromatographed with that of DNA 
reacted with benz(a)anthracene S&oxide (e -0). (B) 
Hydrolysate of DNA reisolated after incubation with 3 H-8,9- 
dihydro-8,9-dihydroxybenz(a)anthracene and a microsomal 
preparation (o -0). cochromatographed with that of DNA 
reacted with b~z(a)an~racene 5,6-oxide (* -*). (0 
Hydrolysate of DNA reacted with 8,9dihydro-8,9-dihydroxy- 
benz(a)anthracene lo,1 l-oxide. 
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3. Rest&s and discussion 
The Sephadex LH20 column chromatographic 
system used here separated polycyclic hydrocarbon- 
deoxyribonucleoside products present in DNA 
hydrolysates from unreacted eoxyribonucleosides 
[7,13] which elute earlier (fig. IA, I, II and IV; fig. 
1 B, I, Ii and V; fig. 1 C, I; fig_ 2, I, II and V; fig. 3, I, 
II and IV). When a mixture of hydrolysates of (a) DNA 
from hamster embryo cells that had been treated with 
’ H-labelled benz(a)anthracene and (b) DNA that had 
been reacted with benz(a)anthracene 5,6-oxide was 
examined by Sephadex LH20 column chromatography, 
the elution profiles of the two hydrolysates differed 
(fig, I A). This confirms previous findings with 7- 
methylbenz(a)an~racene [7]. Hydrolysates of DNA 
that had been incubated with 3 H-labelled 8,9-dihydro- 
8,9-dihydroxybenz(a)anthracene and microsomes 
gave profiles that showed the presence of a radioactive 
product (fig. lB, III) in a position similar to that 
occupied by the product (fig. IA, III) obtained from 
hydrocarbon-treated cells: DNA-products were not 
formed in microsomal incubations that lacked the 
cofactors necessary for the monooxygenase. This result 













benz(a)anthracene, one of the principle metabolites of 
this hydrocarbon in cells, may be involved in the reac- 
tions with DNA that occur following treatment of 
these cells with benz(a)anthracene. Metabolic oxida- 
tion of the isolated IO,1 1 double bond present in the 
8,9-diol seemed likely and, when the synthetic 10,l l- 
oxide was prepared [1 I] and reacted with DNA, the 
profile shown in fig. 1 C was obtained from the hydroly- 
sate. The peak (fig. I C, II) that eluted in the region 
normally occupied by DNA-hydrocarbon products [7] 
was in a position similar to that of the product from 
the DNA of benz(a)anthracene-treated cells(fig. 1 A, 
III). 
Further comparisons confirmed this close similarity. 
Fig. 2 shows the elution profiles obtained when hy- 
drolysates of (a) DNA reacted with 8,9-dihydro-8,9- 
dihydroxy 10,l l-oxide and (b) DNA that had been 
incubated-with 3 H-labelled 8,9-dihydro-8,9dihydroxy- 
be~z~a)ant~acene a dmicrosom~s were mixed and 
chromatographed onthe same Sephadex column. The 
elution profdes obtained when hydrolysates of (a) 
DNA reacted with 8,9~~ydro-8,9~i~lydroxybenz(a) 
anthracene 10, 11 -oxide and (b) DNA from 3 H-labelled 
benz(a)anthracene tr ated cells were mixed and 





Fig. 2. Sephadex LH20 column efution profiles obtained from a hydrolysate of DNA reisolated after incubation with 3 H-8,Qdihydro- 
8,9dihydroxybenz(a)anthracene and a microsomal preparation (o -0) and co-chromatographed with that of DNA reacted with 
8,9dihydro-8,9-dihydroxybenz(a)anthracene lo,1 l-oxide (a-----*). 
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Fig. 3. Sephadex LH20 column elution profiles obtained from a hydrolysate of DNA from hamster embryo cells treated with 3H- 
benz(a)anthracene (o o) co-chromatographed with that of DNA reacted with 8,9-dihydro-8,9-dihydroxybenz(a)anthracene 10, 
11-oxide (o o). 
present in the coincident peaks (fig. 2, III, IV and fig. 3, 
III, V) were further examined by thin-layer chromato- 
graphy. The results obtained showed that in reactions 
with DNA, 8,9-dihydro-8,9-dihydroxybenz(a)anthracene 
10,11-oxide and the microsomal metabolite of 8,9- 
dihydro-8,9-dihydroxybenz(a)anthracene gave products 
that were not separable, in the two solvent systems 
used, from the DNA products that are formed in cells 
treated with benz(a)anthracene. 
Although restricted to benz(a)anthracene, the
evidence presented strongly supports the general con- 
cept that epoxides are the activated intermediates 
that are formed from polycyclic hydrocarbons by 
metabolism and that react with cellular nucleic acids. 
Investigations are in progress to determine whether 
diol-epoxides that are similar in structure to 8,9-dihydro- 
8,9-dihydroxybenz(a)anthracene 10,11-oxide are 
involved in the reactions of other, more carcinogenic, 
hydrocarbons with cellular nucleic acids. In addition, 
the possible biological activity of diol-epoxides i
being examined and explanations for the apparent 
reactivity of this type of epoxide with the DNA of cells 
in culture are being sought. 
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